JENESLIN Trademark

Trademark Overview

On Tuesday, August 15, 2017, a trademark application was filed for JENESLIN with the United States Patent and Trademark Office. The USPTO has given the JENESLIN trademark a serial number of 87569755. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 12, 2021. This trademark is owned by United Therapeutics Corporation. The JENESLIN trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals; pharmaceutical preparations used in the treatment of cardiovascular, pulmonary, and vascular diseases; pharmaceutical preparations used in the treatment of cardiopulmonary and cardiovascular diseases
jeneslin

General Information

Serial Number87569755
Word MarkJENESLIN
Filing DateTuesday, August 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals; pharmaceutical preparations used in the treatment of cardiovascular, pulmonary, and vascular diseases; pharmaceutical preparations used in the treatment of cardiopulmonary and cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Monday, April 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 19, 2020EXTENSION 5 GRANTED
Monday, August 17, 2020EXTENSION 5 FILED
Wednesday, August 19, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 17, 2020TEAS EXTENSION RECEIVED
Friday, March 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020EXTENSION 4 GRANTED
Wednesday, March 4, 2020EXTENSION 4 FILED
Wednesday, March 4, 2020TEAS EXTENSION RECEIVED
Wednesday, July 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2019EXTENSION 3 GRANTED
Monday, July 8, 2019EXTENSION 3 FILED
Monday, July 8, 2019TEAS EXTENSION RECEIVED
Wednesday, February 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2019EXTENSION 2 GRANTED
Monday, February 25, 2019EXTENSION 2 FILED
Monday, February 25, 2019TEAS EXTENSION RECEIVED
Thursday, August 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 21, 2018EXTENSION 1 GRANTED
Tuesday, August 21, 2018EXTENSION 1 FILED
Tuesday, August 21, 2018TEAS EXTENSION RECEIVED
Tuesday, March 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 16, 2017ASSIGNED TO EXAMINER
Monday, August 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

jeneslin cardiovascular treatment diseases used preparations pharmaceutical cardiopulmonary pharmaceuticals pulmonary vascular